King Pharmaceuticals News
Most Popular King Pharmaceuticals Story
King Pharma loses patents for top-selling Skelaxin
In a blow to King Pharmaceuticals, a judge at the U.S. District Court in New York invalidated two of three patents for the drugmakers' top selling drug, muscle relaxant Skelaxin. The patent challenge Read more...
Latest Headlines
- March 17, 2011
- December 16, 2010
- November 3, 2010
- October 27, 2010
- October 13, 2010
- October 12, 2010
- September 8, 2010
- July 26, 2010
- December 9, 2009
- November 24, 2009
- August 13, 2009
- April 27, 2009
- February 3, 2009
- January 21, 2009
- November 24, 2008
- October 7, 2008
- September 11, 2008
- September 2, 2008
- August 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
